Cardiomyocyte PAI-1 influences the cardiac transcriptome and limits the extent of cardiac fibrosis in response to left ventricular pressure overload

• Published in: Cellular signalling 2023-04, Vol.104, p.110555-110555, Article 110555
• Main Authors: Ghosh, Asish K., Kalousdian, Anthony A., Shang, Meng, Lux, Elizabeth, Eren, Mesut, Keating, Anna, Wilsbacher, Lisa D., Vaughan, Douglas E.
• Format: Article
• Language: English
• Subjects: Animals; Cardiac fibrosis; Cardiac hypertrophy; Cardiomyocyte; Cardiomyopathies - pathology; Cytokines - metabolism; Disease Models, Animal; Epigenetic regulators; Fibrosis; Inflammation; Metabolism; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium - metabolism; Myocytes, Cardiac - metabolism; PAI-1; Plasminogen Activator Inhibitor 1 - metabolism; Transcriptome; Transcriptome analysis; Ventricular Pressure; Ventricular Remodeling
• ISSN: 0898-6568; 1873-3913
• DOI: 10.1016/j.cellsig.2022.110555

Plasminogen activator inhibitor-1 (PAI-1) is a specific and rapid-acting inhibitor of endogenous plasminogen activators (uPA and tPA). The global PAI-1 knockout mice (PAI-1KO) develop age-dependent cardiac-selective fibrosis, and young global PAI-1KO mice exhibit augmented susceptibility to developing cardiac fibrosis in response to hypertension. Here, we tested the hypothesis that cardiomyocyte PAI-1 is necessary to provide cardioprotective effects in a left ventricular pressure overload-induced murine model of cardiac hypertrophy and fibrosis using cardiomyocyte-specific PAI-1 knockout (cmPAI-1KO) mice. The results revealed that cmPAI-1KO mice display significantly worse cardiac fibrosis than controls. To investigate the molecular mechanisms responsible for these effects, genome-wide cardiac transcriptome analysis was performed. Loss of cardiomyocyte PAI-1 led to differential expression of 978 genes compared to controls in response to left ventricular pressure overload. Pathway enrichment analysis identified the inflammatory response, cell substrate adhesion, regulation of cytokine production, leukocyte migration, extracellular matrix organization, and cytokine-mediated signaling pathways as being significantly upregulated in cmPAI-1KO hearts. Conversely, specific epigenetic repressors, cation transmembrane transport, muscle system processes, and nitric oxide signaling were significantly downregulated in cmPAI-1KO hearts compared to control hearts in response to left ventricular pressure overload. Collectively, the present study provides strong evidence of the impact of cardiomyocyte PAI-1 in regulation of the transcriptome network involved in the cardiac stress response. In response to stress, the deregulatory impact of cardiomyocyte PAI-1 loss on the cardiac transcriptome may be the underlying cause of cardiac-selective accelerated fibrogenesis in global PAI-1-deficient mice. [Display omitted] •Cardiomyocyte PAI-1 deficiency is associated with stress-induced cardiac fibrosis possibly through fibroblast activation.•This work describes the enormous influence of cardiomyocyte PAI-1 in modulation of the complex cardiac transcriptome.•Cardiomyocyte PAI-1 is protective against stress-induced acceleration of cardiac fibrosis.